Finrate 145 Tablet is a medicine used to treat high cholesterol. This medicine helps by lowering triglycerides and "bad" cholesterol (LDL), while at the same time raising the levels of "good" cholesterol (HDL). Lowering cholesterol levels reduces the risk of heart attack and stroke.

Finrate 145 Tablet is a medicine used to reduce triglyceride and high cholesterol levels. It increases HDL (high density lipoprotein) levels, which helps to reduce the risk of having any heart diseases. Lifestyle changes such as intake of low-fat diets, exercise and weight loss, cessation of alcohol, etc. help in better results. It may cause increased liver enzymes, nausea, flatulence, abdominal pain, and diarrhea as side effects.

Uses of Finrate Tablet

High cholesterol

Benefits of Finrate Tablet

In High cholesterol

Finrate 145 Tablet effectively reduces the high cholesterol levels in your body. Lowering the amount of cholesterol reduces the chances of heart diseases and helps you remain healthier for longer. Take it regularly and make appropriate lifestyle changes (such as eating healthy and staying active) to maximize the effectiveness of this medicine. Keep taking it even if you feel well.

Side effects of Finrate Tablet

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Common side effects of Finrate

Increased liver enzymes
Nausea
Vomiting
Flatulence
Abdominal pain
Diarrhea
Headache
Back pain
Increased creatine phosphokinase (CPK) level in blood
Inflammation of the nose

How to use Finrate Tablet

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Finrate 145 Tablet is to be taken with food.

Safety advice

Alcohol

UNSAFE

It is unsafe to consume alcohol with Finrate 145 Tablet.

Pregnancy

CONSULT YOUR DOCTOR

Finrate 145 Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.

Breast feeding

CONSULT YOUR DOCTOR

Finrate 145 Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.

Driving

SAFE

Finrate 145 Tablet does not usually affect your ability to drive.

Kidney

CAUTION

Finrate 145 Tablet should be used with caution in patients with kidney disease. Dose adjustment of Finrate 145 Tablet may be needed. Please consult your doctor.
Use of Finrate 145 Tablet is not recommended in patients with severe kidney disease.

Liver

UNSAFE

Finrate 145 Tablet is probably unsafe to use in patients with liver disease and should be avoided. Please consult your doctor.
Use of Finrate 145 Tablet is not recommended in patients with severe liver disease.

All substitutes

For informational purposes only. Consult a doctor before taking any medicines.

Finrate 145 Tablet

₹13.4/Tablet

Fenolip 145 Tablet

Cipla Ltd

₹23.51/tablet

75% costlier

Stanlip 145mg Tablet

Sun Pharmaceutical Industries Ltd

₹8.08/tablet

40% cheaper

Feno-TG Tablet

Troikaa Pharmaceuticals Ltd

₹20.03/tablet

49% costlier

Fenotor Tablet

Prevento Pharma

₹10.3/tablet

23% cheaper

Finograt 145mg Tablet

Roussel Laboratories Pvt Ltd

₹11/tablet

18% cheaper

View all substitutes

Quick tips

It should be taken with food.
Avoid alcohol consumption while taking this medication.
Your doctor may check your liver function before starting treatment and regularly thereafter. Notify your doctor if you are more tired than usual, do not feel hungry, or if you have yellow eyes, skin or dark urine.
Inform your doctor if you experience muscle pain, tenderness, cramps, or weakness while taking Finrate 145 Tablet, particularly if it is accompanied by a fever.
Do not discontinue Finrate 145 Tablet without consulting your doctor even if you feel better.

Fact Box

Chemical Class

PPAR alpha

Habit Forming

Therapeutic Class

CARDIAC

Action Class

PPAR alpha agonists (Fibrate)

Patient concerns

High diabetes High cholesterol

Dr. Sanjay Bhatt

Physician

Send reports Need to take medicineAnd what medicine are you taking alreadyA person can control his or her sugar levels by regular exercise and walk or regular aerobic exercises at least 30 to 45 minutes per day.MEDICAL NUTRITIONAL THERAPY THAT IS TO MAINTAIN CALORIES INTAKE AS PER BMI .TAKE HELP OF DIABETIC EDUCATOR. VISIT YOU DOCTOR AND LOW ALL WHAT DOCTOR SUGGESTED.IN TIME ALL ROUTINE INVESTIGATIONS SHOULD BE DONE.you souls not treat it as disease but start of a healthy life.Uncontrolled sugar levels for long time leads to lower limb weakness which is neuropathy and which is followed by foot ulcers and other complications.online prescription is not allowed without seeing pt.so contact doctor nearby for any change or dose adjustment or visit my clinic at gurgaon sector 52 RdCity snergy multi speciality clinic near SRS MARKET

I HAVE HIGH cholesterol. Cholesterol have in blood.

Dr. Sunil Sekhri

Diabetology

send lab reports copy

High triglyceride, high cholesterol, low vitamin D

Shikha Mishra

Dietetics/Nutrition

eat 6-7 meals per day, which consist fruits, nuts, buttermilk,sprouts,idly,curd eggs,sprouts homecooked food. Drink 3-4 litters of water limit your sugar consumption to 2 spoon per day. Be active whole day for personalized diet chart write to me on [email protected] do minimum 45 min exercise everyday like yoga, cardioAvoid biscuits namkeen bakery fruit juices

FAQs

When should Finrate 145 Tablet be taken?

Usually, Finrate 145 Tablet is taken once daily with a meal. The initial dose of the medicine will depend on the type and age of the patient. Consult your doctor before you start taking the medication and follow the instructions as provided.

Does Finrate 145 Tablet raise blood pressure?

There is no or negligible effect on blood pressure in patients with normal blood pressure levels. However, Finrate 145 Tablet may lead to a decrease in blood pressure in patients with high blood pressure.

What drugs should not be taken with Finrate 145 Tablet?

There are few drugs like Oral Anticoagulants or blood thinners, ciclosporin, cholesterol-lowering medications like statins and contraceptives are contraindicated while you take Finrate 145 Tablet. Along with that, there are certain medicines which should not be taken with Finrate 145 Tablet and therefore you must give a proper history to your doctor regarding your ongoing medication. This is done to analyze the condition and provide a proper therapy and prescription which will help minimizing the side effects of the medication.

Can Finrate 145 Tablet cause kidney problems?

Finrate 145 Tablet should be used with caution in patients with kidney disorders. Serum creatinine levels may increase with long-term usage of Finrate 145 Tablet but is completely reversible. The evidence of kidney damage with this medicine is rare still the kidney function blood test should be done regularly if there is a possibility of kidney damage. Consult your doctor before taking the medicine. Inform the doctor if you have had any disease and all the medicines that you are taking for a better diagnosis and treatment.

Can I take grapefruit juice with Finrate 145 Tablet?

Yes, you can take Finrate 145 Tablet with grapefruit juice. The possibility of interaction of the medicine with grapefruit is unlikely as they are broken down in our body by different enzymes. However, if in doubt then limit the intake of grapefruit juice while taking Finrate 145 Tablet.

Show less

Related lab tests

Cholesterol - HDL

Cholesterol - LDL

Cholesterol - Total

Related ayurvedic ingredients

Walnut

Sunflower

Oats

Top Cardiologists

Dr. R. R. Kasliwal

MBBS, MD, DM, Fellowship

4.7 ★

Dr. Subrata Lahiri

MBBS, MD, DNB

4.9 ★

Dr. Pankaj Kumar Singh

4.9 ★

4.6 ★

MBBS, MD, DM, Fellowship, Fellowship

4.5 ★

Want to share the information?

Disclaimer:

Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.

References

Malloy MJ, Kane JP. Agents Used in Dyslipidemia. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 614-15.
Gotto AM Jr, Opie LH. Lipid-Modifying Antiatherosclerotic Drugs. In: Opie LH, Gersh BJ, editors. Drugs for the Heart. 8th ed. Philadelphia, Pennsylvania: Elsevier Saunders; 2013. pp. 425-26.
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 536-37.
Fenofibrate. Saint-Quentin-Fallavier, France: Aenova France SAS; 1993 [revised Apr. 2015]. [Accessed 18 Mar. 2019] (online) Available from:
Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006. Fenofibrate. [Updated 2018 Dec 3]. [Accessed 19 Feb. 2020] (online) Available from:
Fenofibrate [Prescribing Information]. Philadelphia, PA: Frontida BioPharm, LLC; 2023. [Accessed 26 June 2023] (online) Available from:

Marketer details

Name: Serwina Pharmaceuticals Private Limited

Address: No. 108/1, Chekkady Street, Kovur, Chennai-600128

Country of origin: India

The list of available options shown with the same composition has been prepared upon the advice of registered medical practitioners, pharmacists affiliated with TATA 1MG. TATA 1MG does not promote any pharmaceutical product of any particular company, and all recommendations are based on the medical opinion, advisories from specialist medical and pharmaceutical professionals.